A federal appeals court heard argument about whether to freeze preventative health screenings and care in the Affordable Care Act (ACA); Canadian wildfires trigger health threats as smoke descends south; a large study displayed the safety of COVID-19 mRNA vaccines in young children.
Appeals Court Deliberating on ACA Freeze
A federal appeals court panel seemed suspicious on Tuesday of calls to execute a nationwide freeze on the Affordable Care Act (ACA) rules for no-cost coverage of preventive care while litigation in the Braidwood v Becerra case continues, reported Politico. Both sides agreed that the individual Texas businesses that sued over the mandate should be protected as litigation proceeds; they were divided on if more harm would be caused by keeping the current coverage rules unbroken for everyone else in the country, or by suspending them nationwide. The Biden administration warned that halting coverage would threaten access to more than 50 types of care for millions of Americans.
Wildfire Smoke Triggers Health Alerts
Officials across nearly half of the United States issued warnings about the health threats from air polluted by smoke from unprecedented early summer wildfires in eastern Canada, according to The New York Times. Wildfire smoke can cause harm even at low concentrations, and those with lung or heart diseases, older adults, children, and pregnant women are at higher risk, said Environment Canada. In New York City, field trips were canceled, and some commuters returned to waring masks if they had to be outdoors.
Large Study Demonstrates COVID-19 Vaccine Safety in Young Children
Messenger RNA vaccines for COVID-19 present little risk to young children, with no myocarditis (inflammation of heart muscle) or pericarditis (inflammation around the heart) seen in vaccine recipients age 0 to 4, reported CIDRAP. Data were collected via the Vaccine Safety Datalink and in collaboration with the CDC that obtained patient information from 8 major US health systems. Children were followed for 9 months. However, vaccine uptake in the age group was low.
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
ICYMI: Highlights From AMCP Nexus 2024
December 26th 2024Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.
Read More